New Targets in the Drug Treatment of Heart Failure.
- Published in:
- Drugs, 2016, v. 76, n. 2, p. 187, doi. 10.1007/s40265-015-0498-3
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2016 AND VI 76 AND IP 2
Results: 11
1
2
Therapies to Preserve β-Cell Function in Type 1 Diabetes.
- Published in:
- Drugs, 2016, v. 76, n. 2, p. 169, doi. 10.1007/s40265-015-0511-x
- By:
- Publication type:
- Article
3
An Update on Medical Treatment Options for Hidradenitis Suppurativa.
- Published in:
- Drugs, 2016, v. 76, n. 2, p. 215, doi. 10.1007/s40265-015-0516-5
- By:
- Publication type:
- Article
4
Antidepressant Drugs for Postsurgical Pain: Current Status and Future Directions.
- Published in:
- Drugs, 2016, v. 76, n. 2, p. 159, doi. 10.1007/s40265-015-0517-4
- By:
- Publication type:
- Article
5
Ceftolozane/Tazobactam: A Review in Complicated Intra-Abdominal and Urinary Tract Infections.
- Published in:
- Drugs, 2016, v. 76, n. 2, p. 231, doi. 10.1007/s40265-015-0524-5
- By:
- Publication type:
- Article
6
Dimethyl Fumarate: A Review in Relapsing-Remitting MS.
- Published in:
- Drugs, 2016, v. 76, n. 2, p. 243, doi. 10.1007/s40265-015-0528-1
- By:
- Publication type:
- Article
7
Osimertinib: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 2, p. 263, doi. 10.1007/s40265-015-0533-4
- By:
- Publication type:
- Article
8
Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
- Published in:
- Drugs, 2016, v. 76, n. 2, p. 255, doi. 10.1007/s40265-015-0535-2
- By:
- Publication type:
- Article
9
Daratumumab: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 2, p. 275, doi. 10.1007/s40265-015-0536-1
- By:
- Publication type:
- Article
10
Necitumumab: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 2, p. 283, doi. 10.1007/s40265-015-0537-0
- By:
- Publication type:
- Article
11
Diagnosis and Management of Systemic Sclerosis: A Practical Approach.
- Published in:
- Drugs, 2016, v. 76, n. 2, p. 203, doi. 10.1007/s40265-015-0491-x
- By:
- Publication type:
- Article